All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

9

Reset

9 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • REGN7508CenvacibartPhase 312 trials

    Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism

  • REGN9933amrecibartPhase 35 trials

    Regeneron · Atrial Fibrillation (AF), Peripheral Artery Disease (PAD), Venous Thromboembolism (VTE)

  • AbelacimabMAA868Phase 33 trials

    Anthos Therapeutics, Inc. · Atrial Fibrillation (AF), Stroke

  • MilvexianJNJ-70033093, BMS-986177Phase 33 trials

    Johnson & Johnson (Janssen) · Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation, Acute Coronary Syndrome

  • VortosiranPhase 22 trials

    Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)

  • AP31969Phase 21 trial

    Acesion Pharma · Atrial Fibrillation (AF)

  • BAY 3670549Phase 21 trial

    Bayer · Atrial Fibrillation

  • HBI-3000sulcardine sulfatePhase 21 trial

    HUYABIO International, LLC. · Atrial Fibrillation

  • PKN605Phase 21 trial

    Novartis · Atrial Fibrillation

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.